- Corporate Officers - K
- Kim Mina
Insider Trading History of Kim Mina
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kim Mina since 2022.
This trader's CIK number is 1668163.
At the time of last reporting, Kim Mina was the Chief Executive Officer of Acelyrin, Inc.. (stock ticker symbol SLRN).
Also see all insider trading activities at Acelyrin, Inc..
Note that in the past
Kim Mina also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Acelyrin, Inc. (SLRN) by Kim Mina
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | SLRN | 0 | $0 | 17,986 | $49,353 | 0 | $0 |
2023 | SLRN | 5,000 | $90,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zymergen Inc. (ZY) by Kim Mina
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | ZY | 0 | $0 | 15,573 | $30,154 | 0 | $0 |
Insider trading activities at 2 companies by Kim Mina:
1. Acelyrin, Inc. (SLRN)
2. Zymergen Inc. (ZY)
Table 1. Insider trading of Acelyrin, Inc. (SLRN) by Kim Mina
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-03-17 | SLRN | Sale | 17,986 | 2.74 | 49,353 |
2023-05-09 | SLRN | Buy | 5,000 | 18.00 | 90,000 |
Table 2. Insider trading of Zymergen Inc. (ZY) by Kim Mina
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-09-02 | ZY | Sale | 3,410 | 2.21 | 7,536 |
2022-08-02 | ZY | Sale | 3,094 | 2.61 | 8,084 |
2022-07-05 | ZY | Sale | 2,924 | 1.32 | 3,865 |
2022-06-02 | ZY | Sale | 2,939 | 1.68 | 4,931 |
2022-05-02 | ZY | Sale | 3,206 | 1.79 | 5,738 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kim Mina
(Chief Executive Officer of Acelyrin, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.